Suchergebnisse - "Merz, Valeria"

PubPharm (44)

31

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer : the nITRO trial

enthalten in: Therapeutic advances in medical oncology | 2020

von Simionato, F. | Zecchetto, C. | Merz, V. | +31

32

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant : the FiGhTeR trial

enthalten in: Therapeutic advances in medical oncology | 2020

von Merz, V. | Zecchetto, C. | Simionato, F. | +16

33

NUT midline carcinoma : Current concepts and future perspectives of a novel tumour entity

enthalten in: Critical reviews in oncology/hematology | 2019

von Salati, M. | Baldessari, C. | Bonetti, L. | +4

34

Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer

enthalten in: Journal of gastric cancer | 2019

von Cavaliere, A. | Merz, V. | Casalino, S. | +6

35

Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Gueorguieva, I. | Tabernero, J. | Melisi, D. | +7

36

Adjuvant chemotherapy in resected bile duct cancer : A systematic review and meta-analysis of randomized trials

enthalten in: Critical reviews in oncology/hematology | 2019

von Messina, C. | Merz, V. | Frisinghelli, M. | +7

37

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

enthalten in: JAMA surgery | 2019

von Maggino, L. | Malleo, G. | Marchegiani, G. | +21

CommentIn: JAMA Surg. 2019 Oct 1;154(10):942. - PMID 31339517

38

Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Gueorguieva, I. | Tabernero, J. | Melisi, D. | +7

39

Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Gueorguieva, I. | Tabernero, J. | Melisi, D. | +7

40

Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Gueorguieva, I. | Tabernero, J. | Melisi, D. | +7